Joyce O’Shaughnessy, M.D., Cynthia Osborne, M.D., John E. Pippen, M.D., Mark Yoffe, M.D., Debra Patt, M.D.,
Christine Rocha, M.Sc., Ingrid Chou Koo, Ph.D., Barry M. Sherman, M.D., and Charles Bradley, Ph.D.*

Nitin Verma and Sandra M. Swain, Washington Cancer Institute, Washington Hospital Center, Washington, DC

Farhad Islami a,b,c, Veronika Fedirko a, Irene Tramacere d, Vincenzo Bagnardi e,f, Mazda
Jenab a, Lorenza Scotti e, Matteo Rota e,g, Giovanni Corrao e, Werner Garavello d,h,
Joachim Schüz a, Kurt Straif a, Eva Negri d, Paolo Boffetta i,j, Carlo La Vecchia d,k

TO THE EDITOR

JCK Leung1, LYY Chan1, SCW Tang1, KM Chu2 and KN Lai1

RH Mak1, W Cheung1, RD Cone2 and DL Marks1

ANTONIO PICCOLI, FOR THE ITALIAN CAPD-BIA STUDY GROUP

BRAD H. ROVIN, HUIJUAN SONG, LEE A. HEBERT, TIBOR NADASDY, GYONGYI NADASDY,
DANIEL J. BIRMINGHAM, CHACK YUNG YU, and HAIKADY N. NAGARAJA

ALICIA MARCHLEWSKA, PETER STENVINKEL, BENGT LINDHOLM, ANDERS DANIELSSON,
ROBERTO PECOITS-FILHO, FREDRIK LO¨ NNQVIST, MARTIN SCHALLING, OLOF HEIMBU¨ RGER,
and LOUISE NORDFORS

Laurent Yvan-Charvet1 and Annie Quignard-Boulange´ 2,3